Clinical Trial Update: A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2) [Phase 3]

View source ↗

Summary

This is a Phase 3 pivotal safety and efficacy study of OCS-01 Eye Drops for diabetic macular edema, with the DIAMOND 2 trial currently listed as ACTIVE_NOT_RECR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• OCS-01 Eye Drops (OCS-01)

Snippet

Sponsor: Oculis | Conditions: Diabetic Macular Edema | Phase 3 | Status: ACTIVE_NOT_RECRUITING